Bulletin
Investor Alert

New York Markets Open in:

April 27, 2022, 8:06 a.m. EDT

Deadline Friday Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Cabaletta Bio Inc. (CABA)

or Cancel Already have a watchlist? Log In

Los Angeles, California, Apr 27, 2022 (Newsfile Corp via COMTEX) -- Los Angeles, California--(Newsfile Corp. - April 27, 2022) - The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc. ("Cabaletta" or "the Company") /zigman2/quotes/214676209/composite CABA +5.52% for violations of the federal securities laws.

Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on October 24, 2019 (the "IPO"), or between October 24, 2019 and December 13, 2021, inclusive (the "Class Period"), are encouraged to contact the firm before April 29, 2022.

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com , or by email at brian@schallfirm.com .

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Cabaletta's Phase 1 trial for DSG3-CAART produced top-line data showing it worsened some participants' disease activity scores and resulted in a need for further medication. DSG3-CAART was not as effective as the Company touted to investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Cabaletta, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE:

The Schall Law Firm

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/121820

COMTEX_406323955/2523/2022-04-27T08:06:17

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

copyright (c) newsfile corp. 2022. all rights reserved

/zigman2/quotes/214676209/composite
US : U.S.: Nasdaq
$ 1.53
+0.08 +5.52%
Volume: 292,096
Aug. 12, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$44.34 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.